Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;43(4):866-76.
doi: 10.1002/jmri.25051. Epub 2015 Sep 28.

Feasibility and reproducibility of BOLD and TOLD measurements in the liver with oxygen and carbogen gas challenge in healthy volunteers and patients with hepatocellular carcinoma

Affiliations

Feasibility and reproducibility of BOLD and TOLD measurements in the liver with oxygen and carbogen gas challenge in healthy volunteers and patients with hepatocellular carcinoma

Octavia Bane et al. J Magn Reson Imaging. 2016 Apr.

Abstract

Purpose: To quantify baseline relaxation rates R2* and R1 in the abdomen, their changes after respiratory challenges, and their reproducibility in healthy volunteers and patients with hepatocellular carcinoma (HCC) at 1.5T and 3.0T.

Materials and methods: R2* measurements were acquired in the liver in 8 volunteers and 27 patients with 34 HCCs using multiecho T2* at baseline and after respiratory challenges with 100% oxygen (O2 ) and carbogen (CB = 95%O2 /5%CO2 ). R1 was measured at 1.5T in one volunteer and 21 patients with 23 HCCs. Test-retest coefficient of variation (CV) was assessed in 10 subjects. Intra- and interobserver variability of R2* and R1 measurements was assessed in 12 and 10 patients, respectively. Parameters for HCC, liver, and muscle were compared between baseline and after gas challenges.

Results: We observed that R2* and R1 imaging of HCCs with O2 and CB is feasible and reproducible (test-retest CV R2*<15%/R1 <5%; intra- and interobserver intraclass correlation coefficient R2*>0.88/R1 >0.7 and CV R2*<7%/R1 <3% at 1.5T). R2* measurements were observed to be less reproducible at 3.0T (CV<35%). There was a statistically significant decrease in R2* values in HCC before and after O2 (P = 0.02) and increase in R1 after O2 (P = 0.004). CB had no significant effect (P R2* = 0.47/R1 = 0.278).

Conclusion: R2* measurements in HCC and liver parenchyma are more reproducible at 1.5T than at 3.0T, and with O2 than with CB challenge. We observed a decrease in R2* and an increase in R1 of HCCs from baseline in response to O2 challenge, as expected with increased tissue and blood oxygenation.

Keywords: R1; R2*; hepatocellular carcinoma; liver.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
MRI acquisition protocol demonstrating the succession of respiratory challenges for BOLD and TOLD imaging.
FIGURE 2
FIGURE 2
A 67-year-old male patient with left hepatic lobe HCC measuring 5.4 cm (arrow on postcontrast T1WI), which demonstrates a decrease in R2 after O2 (ΔR2 O2=18.7%) and carbogen (ΔR2 CB=20%) gas challenges. HCC shows no significant change in R1 (ΔR1 O2=−1.7%), below the level of physiological variation denoted by test–retest CV=3.6%. The decrease in R2 above the level of physiological variation, accompanied by no significant change in R1, is consistent with baseline hypoxia.
FIGURE 3
FIGURE 3
A 68-year-old male patient with right hepatic lobe HCC treated with chemoembolization. There is central tumor necrosis on postcontrast T1WI (arrow). The viable tumor at the periphery of the lesion demonstrates response to hyperoxia (arrows), with a decrease in R2 under O2 (ΔR2 O2=17%) and carbogen (ΔR2 CB=23.7%). The tumor also shows overall increase in R1 under O2 (ΔR1 O2=−8.5%). This lesion may be normoxic or mildly hypoxic, since the R1 increase with O2 challenge is also substantial.
FIGURE 4
FIGURE 4
Histogram distribution of changes in R2 observed in HCC lesions at 3.0T (patients 1–5) and 1.5T (patients 4–27) with oxygen (O2) and carbogen (CB) gas challenges. The horizontal lines mark the threshold for response ±9% (1.5T CV R2 baseline=±9.1%, 3.0T CV R2 baseline=±8.8%). ΔR2 >0 denotes decrease in R2 from baseline with respiratory challenge (ΔR2 (%)=100*[(R2 baseline − R2 gas)/R2 baseline). Lesions are indexed by patient number and ordered by superior-to-inferior anatomical location. The changes in R2 with O2 are highly variable between individual lesions. With CB, 6/18 lesions at 1.5T and 2/3 lesions at 3T have paradoxical response (increase in R2, ΔR2 <0).
FIGURE 5
FIGURE 5
Histogram distribution of changes in R1 observed in HCC lesions at 1.5T, with oxygen (O2) and carbogen (CB) gas challenges. The horizontal lines mark the threshold for response, CV R1 baseline=3.6%; ΔR1<0 denotes increase in R1 from baseline with respiratory challenge (ΔR1 (%)=100 *[(R1baseline − R1 gas)/R1 baseline). Lesions are indexed by patient number and ordered by superior-to-inferior anatomical location. The majority of lesions show the expected response with O2, increase in R1 (ΔR1<0), while response with CB is variable.
FIGURE 6
FIGURE 6
Histogram distribution comparing R2 and R1 response in HCCs to oxygen (O2) challenge in 22 HCCs. Some tumors show substantial decrease in R2 with oxygen from baseline, and modest/no increase in R1; these are possibly hypoxic (thin arrows). Other tumors show a modest decrease in R2 and substantial increase in R1 (thick arrows); these are possibly normoxic/mildly hypoxic/hyperoxic tumors.

References

    1. Semenza GL. Hypoxia and cancer. 2007;26:223–224. - PubMed
    1. Ghattass K, Assah R, El-Sabban M, Gali-Muhtasib H. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy. Curr Cancer Drug Targets. 2013;13:670–685. - PubMed
    1. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225–239. - PubMed
    1. Howe FA, Robinson SP, McIntyre DJ, Stubbs M, Griffiths JR. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed. 2001;14:497–506. - PubMed
    1. Hallac RR, Zhou H, Pidikiti R, et al. Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response. Magn Reson Med. 2014;71:1863–1873. - PMC - PubMed

Publication types

MeSH terms